Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California / Keck Hospital
Los Angeles, California, United States
- University of California San Francisco
San Francisco, California, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- Florida Hospital Transplant Institute
Orlando, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Lahey Hospital
Burlington, Massachusetts, United States
- Columbia University College of Physicians and Surgeons
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- the Mount Sinai Medical Center
New York, New York, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Methodist University Hospital
Memphis, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor University Medical Center
Dallas, Texas, United States
- Advanced Liver Therapies / St. Luke'S Episcopal Hospital
Houston, Texas, United States
- Houston Methodist
Houston, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- University of Utah Health Sciences Center
Salt Lake City, Utah, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2013
- Primary completion
- 29 Feb 2016
- Completion
- 30 Jun 2016
- Last update posted
- 15 Mar 2017
- Registered enrollment
- 80
- Registry id
- NCT01804829
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.